USPSTF recommends aspirin for prevention of colorectal cancer
the ONA take:
For the first time, the United States Preventive Services Task Force (USPSTF) has issued a broad recommendation to take aspirin to prevent colorectal cancer.
In the draft report, the task force found that low-dose or baby aspirin can help prevent heart attacks, stroke, and colorectal cancer, particularly in high-risk people in their 50’s.
An analysis on colorectal cancer found that aspirin use reduced colorectal cancer-related deaths by 33% and reduced colon cancer incidence by 40%; however, people need to take aspirin for at least 5 to 10 years in order to have a benefit.
“No major health organization has previously recommended the use of aspirin to prevent cancer,” Dr. Eric Jacobs of the American Cancer Society said. “This is a new approach that makes a great deal of sense.”
However, not everyone feels positively about these new recommendations. “People still need to be screened,” Dr. David Johnson of the United Stated Multi-Society Task Force on Colorectal Cancer said. “I have major reservations that the message will be, ‘I take aspirin, so I don’t need to be screened.’”
According to the American Cancer Society, colorectal cancer is the third leading cause of cancer-related deaths in the United States in men and women separately and the second leading cause when combined.
The USPSTF has issued a broad recommendation to take aspirin to prevent colorectal cancer.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
- Sexual Aids and Resources Not Readily Available at Cancer Centers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|